56 information-technology-"https:"-"https:"-"https:"-"https:" Postdoctoral positions in Denmark
Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
read more about it here . The application must be submitted via Aarhus University’s recruitment system, which can be accessed under the job advertisement on Aarhus University's website.
-
facilities within the center and this means through PREDICT you will be part of a well-funded research environment equipped with the latest technologies, unique data, and a world leading network of
-
. Experience with one or more of the following will be considered an advantage: RNA sequencing or other omics technologies, including data analysis; advanced microscopy or image analysis; renal physiology
-
thereafter. The position is a fixed-term full-time position for 36 months/ 3 years. The department of Biomedicine prioritises diversity and a good work environment, as this is a prerequisite for groundbreaking
-
University also offers a Junior Researcher Development Programme targeted at career development for postdocs at AU. You can read more about it here . The application must be submitted via Aarhus University’s
-
& ecosystem structure under rising biosphere novelty. The work will integrate ecological, demographic, environmental and remote-sensing information to develop scenario-based forecasts of European vegetation and
-
the Niels Bohr Institute. It functions as a primary center for fundamental research including theoretical and computational astrophysics, particle astrophysics, gravitational physics, high energy particle
-
qualifications at PhD level, in medical physics, physics, biomedical engineering or computer science. It is mandatory that your PhD degree is on a topic relevant for this specific position, i.e. in CT-imaging and
-
thereafter. The position is a fixed-term full-time position for 2 years. The department of Biomedicine prioritises diversity and a good work environment, as this is a prerequisite for groundbreaking research
-
to unlocking the full potential of nucleic acid–based therapeutics is their inefficient delivery to the cytosol. Current technologies like lipid nanopartcles (LNPs) are limited by poor biodistribution and